Welcome to our dedicated page for DNA X SEC filings (Ticker: SONM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Sonim Technologies, Inc. (NASDAQ: SONM) provides direct access to the company’s official regulatory disclosures, along with AI-powered tools to help interpret complex documents. These filings trace Sonim’s history as a rugged mobile solutions provider and its transition toward a new business focus on the DNA X decentralized finance trading platform.
Investors can review Form 10-Q and 10-K reports (when available) for detailed discussions of net revenues from phones, wireless internet data devices, accessories, and software, as well as information on operating expenses, liquidity, and risk factors. Quarterly earnings releases are often furnished on Form 8-K, as seen in the October 31, 2025 filing that attaches Sonim’s third quarter 2025 financial results and commentary on product launches and the pending asset sale to NEXA.
Multiple Form 8-K filings document material events central to understanding SONM’s evolution. These include the July 2025 asset purchase agreement with a buyer affiliated with Social Mobile (later referenced as NEXA) to acquire substantially all assets related to Sonim’s enterprise 5G solutions and rugged mobility business; the November 24, 2025 amendment to that agreement; Nasdaq listing notices; and the October 2025 reverse stock split and authorized share increase. A December 18, 2025 Form 8-K details the convertible promissory note with DNA Holdings Venture, Inc. and the membership interest purchase agreement through which Sonim acquired DNA X LLC, a company engaged in the DNAX DeFi on-chain trading protocol.
Registration statements such as the Form S-1 and S-1/A filed in late 2025 describe Sonim’s committed equity facility with Chardan Capital Markets LLC, outlining how the company may sell newly issued common shares over time, the associated risks, and the potential impact on capital structure. The DEF 14A proxy statement for the October 16, 2025 special meeting provides insight into stockholder votes on the reverse stock split, authorized share increase, and related corporate proposals.
On this page, AI-generated summaries can highlight key points from lengthy filings: for example, how a new financing arrangement works, what conditions apply to the NEXA asset sale, or how the DNA X acquisition affects governance and ownership. Users can quickly identify sections related to strategic transactions, listing compliance, equity and debt financing, and the planned rebranding to DNA X, Inc. For those researching insider activity, the platform also surfaces Form 4 insider transaction reports when filed, enabling a consolidated view of executive and director share dealings.
Together, Sonim’s SEC filings and AI explanations offer a structured way to understand the company’s financial position, strategic decisions, and the regulatory steps behind its shift from rugged mobility to a DeFi-oriented crypto trading platform business.
Sonim Technologies filed an 8-K stating it issued a press release announcing financial results for the fiscal quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1.
Sonim Technologies announced a reverse stock split of its common stock at a 1-for-18 ratio, approved by stockholders and the Board. The split will be effected by a certificate of amendment and will become effective at 12:01 a.m. Eastern Time on October 27, 2025.
Every eighteen shares will combine into one share with no change to par value. No fractional shares will be issued; holders entitled to a fraction will receive cash in lieu based on the October 20, 2025 closing price (as adjusted). The stock will begin trading on a split-adjusted basis on October 27, 2025 under the existing ticker SONM. The new CUSIP will be 83548F 408.
Sonim Technologies reported multiple corporate actions. Nasdaq granted an extension through December 31, 2025 to regain compliance with Listing Rule 5550(b)(1), which requires $2.5 million in stockholders’ equity. The company submitted a compliance plan and noted that failure to meet requirements could lead to delisting.
The board set a 1-for-18 reverse stock split expected to take effect at 12:01 a.m. ET on October 27, 2025, aimed at meeting the minimum bid price. Stockholders approved increasing authorized common shares from 100,000,000 to 1,000,000,000, which was filed and became effective on October 16, 2025. They also approved the reverse split authority, while a proposed 1,000,000‑share increase to the 2019 Equity Incentive Plan was not approved. A quorum was reached with 12,056,361 shares (about 67.8%) represented.
The board appointed Michael Mulica as Executive Chairman effective October 16, 2025, with a $300,000 base salary, an annual $250,000 RSU grant vesting quarterly over two years, and a $500,000 RSU award tied to a specified asset purchase, with cash substitutes possible if plan share availability is insufficient.
Sonim Technologies (SONM): Form 3 filed for a director
A director of Sonim Technologies filed an initial statement of beneficial ownership (Form 3). The filing reports direct ownership of 723 shares of common stock. The event date was 07/18/2025, and the form was filed by one reporting person. No derivative securities were reported.
Sonim Technologies, Inc. filed an amendment to its S-1 registration that registers shares for resale by Chardan and updates pro forma and distribution details. The company may issue up to 350,000,000 additional shares to Chardan under a purchase agreement, which combined with existing outstanding shares of 10,338,905 could total 360,338,905 shares offered for resale under certain assumptions. The Purchase Agreement limits issuance to no more than 19.99% of pre-transaction outstanding shares unless stockholder approval or the Nasdaq Minimum Price of $0.6277 is met; Chardan is further restricted from exceeding 4.99% beneficial ownership.
The company estimates it may receive up to $500.0M of aggregate gross proceeds from sales to Chardan, although actual proceeds depend on shares sold and prices; at least 33% of proceeds will prepay the July Note. Pro forma adjustments reflect an estimated transaction expense accrual of $1,250, severance of $2,137, recognition of a gain on an Asset Sale of $12,074, and application of a 21% statutory tax rate. The filing discloses potential FINRA conflict-of-interest compliance for Chardan acting as executing broker and includes customary risk factor and forward-looking statement language.
Sonim Technologies registers a shelf to allow resale by a selling securityholder and to support an at-the-market-style purchase agreement under which the company may sell up to 350,000,000 shares to Chardan. The company had 10,338,905 shares outstanding at June 30, 2025 in the disclosure and estimates it could receive up to $500.0 million in aggregate gross proceeds from sales to Chardan, subject to sales prices, discounts and Nasdaq issuance limits. At least 33% of proceeds from sales to Chardan would be applied to prepayment of the July Note. Issuances to Chardan are limited by a 19.99% Exchange Cap and a 4.99% beneficial ownership cap, and the Purchase Agreement contains a Nasdaq Minimum Price of $0.6277 per share. Resales by Chardan present a FINRA Rule 5121 conflict of interest; resales will follow FINRA procedures.
Sonim Technologies entered a committed equity facility with Chardan Capital Markets that allows Sonim, at its option, to sell newly issued common shares for up to $500,000,000 in aggregate gross purchase price, subject to limits including an exchange cap of 2,066,747 shares, equal to 19.99% of shares outstanding before the agreement. Sales will be priced off the stock’s volume weighted average price with a fixed 3.5% discount and can occur over a 36‑month period after the resale registration statement becomes effective.
Chardan’s beneficial ownership is capped at 4.99% of outstanding shares, and per‑day purchases are further limited by dollar, trading‑volume and contract thresholds. Sonim plans to use at least 33% of any proceeds to prepay a $2,755,000 promissory note to Streeterville Capital, with the balance intended for operations, working capital and general corporate purposes.
Sonim Technologies, Inc. is asking stockholders to vote at a Special Meeting on October 16, 2025 on four proposals: a reverse stock split, an increase in authorized common shares, an increase in shares under the equity incentive plan, and an adjournment proposal. The board proposes increasing authorized common stock from 100,000,000 to 1,000,000,000 shares and would raise shares reserved under the equity plan from 43,927 to 1,043,927 if approved. The company reports 17,781,919 shares outstanding and 80,381,720 shares available for issuance today (rising to 980,381,720 if the authorized increase is approved). The Nasdaq reported closing price is $0.7536 per share. Named executives include CEO Peter Hao Liu, CFO Clay Crolius, and CCO Charles Becher. Major holders disclosed include AJP/Orbic Group with 11.07%, Laurence Lytton 5.55%, CVI 5.62%, L1 5.62%, and 1 Main 5.07%. The board notes potential benefits of the reverse split but also identifies associated risks.
Sonim Technologies, Inc. is asking stockholders to vote at a Special Meeting on October 16, 2025 on four proposals: a reverse stock split, an increase in authorized common shares, an increase in shares under the equity incentive plan, and an adjournment proposal. The board proposes increasing authorized common stock from 100,000,000 to 1,000,000,000 shares and would raise shares reserved under the equity plan from 43,927 to 1,043,927 if approved. The company reports 17,781,919 shares outstanding and 80,381,720 shares available for issuance today (rising to 980,381,720 if the authorized increase is approved). The Nasdaq reported closing price is $0.7536 per share. Named executives include CEO Peter Hao Liu, CFO Clay Crolius, and CCO Charles Becher. Major holders disclosed include AJP/Orbic Group with 11.07%, Laurence Lytton 5.55%, CVI 5.62%, L1 5.62%, and 1 Main 5.07%. The board notes potential benefits of the reverse split but also identifies associated risks.
Sonim Technologies, Inc. is soliciting votes at a 2025 special meeting on four proposals: a reverse stock split, an increase in authorized common stock from 100,000,000 to 1,000,000,000, an increase in shares reserved under its equity incentive plan, and an adjournment proposal. The company reports 17,781,919 shares outstanding and a Nasdaq closing price of $0.57. If approved, reserved shares for awards would increase from 43,927 to 1,043,927 (illustrative figures shown). The proxy discloses outstanding warrants of 1,133,625 and certain majority and voting thresholds required to approve each proposal.
This Schedule 13G reports that the Reporting Persons collectively beneficially own 908,410 shares of Sonim Technologies, Inc. common stock, representing 5.1% of the class based on 17,738,905 shares outstanding plus 150,000 shares underlying warrants.
The holdings are held across private funds managed by 1 Main Capital: Fund 1 directly holds 622,380 shares plus warrants for 150,000 shares and Fund 2 holds 136,030 shares, with the Adviser (1 Main Capital Management, LLC), the General Partner and Principal Yaron Naymark identified as reporting persons. The filing states the stake was not acquired to influence control and is signed by Yaron Naymark.